The START Center's News - Cancer Research and Treatment Information

START SITC Activity

2022 SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) ACTIVITY SUMMARY The START Center investigators contributed as authors to posters and...

2022 EORTC-NCI-AACR ACTIVITY SUMMARY

2022 EORTC-NCI-AACR ACTIVITY SUMMARY The START Center investigators contributed as authors to posters and abstracts at this year's...

Exelixis Announces Initial Dose-Escalation Results from the First-in-Human Phase 1 Trial Evaluating

ALAMEDA, Calif.--(BUSINESS WIRE)--Dec. 8, 2022-- Exelixis, Inc. (Nasdaq: EXEL) today announced initial results from the ongoing...

START Center for Cancer Care to Open New Locations in Lisbon and Dublin

First oncology early-phase clinical trials units in Portugal and Ireland to offer leading-edge cancer treatments --(BUSINESS WIRE)-- SAN...

Dr. Jay Messer Prostate Cancer Interview on kens5

See Dr. Jay Messer's interview on kens5 as part of National Prostate Cancer Awareness Month. Prostate Cancer Treatment Services | Great...

2022 ESMO Activity Summary

The START Center investigators contributed as authors to 21 posters and abstracts at this year's ESMO meeting in Paris. Congratulations...